Obesity is a serious global health problem that increases the risk for type 2 diabetes and other related diseases like cancer. Unfortunately, current treatments often result in metabolism damage without inducing weight loss. There is thus a clear need for antiobese drugs that improve metabolism and induce weight loss. We have data suggesting that the small ubiquitin-like modifier Sumo is deeply involved in the regulation of adipose tissue function and identity. This research project thus seeks to address the role of Sumo-mediated gene control during adipocyte differentiation at the chromatin level, with a primary focus on human and mouse adipose stem cells.

• Owning a Ph.D. in Biology 
• Extensive laboratory experience in molecular biology, cell biology and biochemistry 
• Experience in ChIP/ChIP-seq, RNA-seq, qPCR 
• Experience in microscopy  
• Programming skills would be a plus 
• Experience with proteomics would be a plus 
• Experience with NGS Bioinformatics would be a plus 
• Full professional proficiency in English    

• Enthusiasm and curiosity
• Willingness to engage into discussion on how’s and why’s
• Drive and commitment to carry out experiments to the end
  

• A dynamic working environment in the research section at Rikshospitalet.
• A very international, young and stimulating work place.